Authors: Booij, J Reneman, L Lavalaye, J Knol, RJJ de Bruin, K Speelman, JD Janssen, AGM

Citation: J. Booij et al., Dopamine transporter imaging as an in vivo marker of dopaminergic neurons, DRUG FUTURE, 26(3), 2001, pp. 271-279

Authors: Reneman, L Booij, J de Bruin, K Reitsma, JB de Wolff, FA Gunning, WB den Heeten, GL van den Brink, W

Citation: L. Reneman et al., Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons, LANCET, 358(9296), 2001, pp. 1864-1869

Authors: Benamer, HTS Patterson, J Grosset, DG Booij, J de Bruin, K van Royen, E Speelman, JD Horstink, MHIM Sips, HJWA Dierckx, RA Versijpt, J Decoo, D Van der Linden, C Hadley, DM Doder, M Lees, AJ Costa, DC Gacinovic, S Oertel, WH Pogarell, O Hoeffken, H Joseph, K Tatsch, K Schwarz, J Ries, V

Citation: Hts. Benamer et al., Accurate differentiation of parkinsonism and essential tremor using visualassessment of [I-123]-FP-CIT SPECT imaging: The [I-123]-FP-CIT study group, MOVEMENT D, 15(3), 2000, pp. 503-510

Authors: Lavalaye, J Knol, RJJ de Bruin, K Reneman, L Janssen, AGM Booij, J

Citation: J. Lavalaye et al., [I-123]FP-CIT binding in rat brain after acute and sub-chronic administration of dopaminergic medication, EUR J NUCL, 27(3), 2000, pp. 346-349

Authors: Booij, J Hemelaar, JTGM Speelman, JD de Bruin, K Janssen, AGM van Royen, EA

Citation: J. Booij et al., One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [I-123]FPCIT SPECT, J NUCL MED, 40(5), 1999, pp. 753-761

Authors: Booij, J Knol, RJJ Reneman, L de Bruin, K Janssen, AGM van Royen, EA

Citation: J. Booij et al., Iodine-123 labelled nor-beta-CIT binds to the serotonin transporter in vivo as assessed by biodistribution studies in rats, EUR J NUCL, 25(12), 1998, pp. 1666-1669